A healthy adult human harbours trillions of microbes that expand our own gene repertoire by at least two orders of magnitude. Our laboratory, shared between Department CIBIO at University of Trento and the Department of Experimental Oncology at IEO, employs multiple complementary approaches coupling computation and experimentation to study the diversity of the human microbiome and its role in human diseases.
We work in a highly multidisciplinary and collaborative environment with effective interactions between computational scientists, experimental biologists, statisticians, and clinical teams.
At DEO, we are specifically interested in understanding the role of the microbiome in:
- Modulating cancer risk.
- Favouring or preventing cancer development.
- Dictating the success of cancer treatment, especially for immunotherapy approaches.
Most Relevant Publications
Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation.
Nat Med, 2019
Extensive Unexplored Human Microbiome Diversity Revealed by Over 150,000 Genomes from Metagenomes Spanning Age, Geography, and Lifestyle.
The Prevotella copri Complex Comprises Four Distinct Clades Underrepresented in Westernized Populations.
Cell Host Microbe, 2019
Mother-to-Infant Microbial Transmission from Different Body Sites Shapes the Developing Infant Gut Microbiome.
Cell Host Microbe, 2018